Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | MAOB | P27338 | 5/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.60 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.49 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7922516 | 1.00 | CYP1B1 (0.64) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL10744603 | 0.97 | KMT2A (0.64) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL10744598 | 0.97 | KMT2A (0.64) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL6915908 | 0.94 | MAOB (0.64) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL11432402 | 0.94 | MAOB (0.64) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL15367534 | 0.92 | MAOB (0.61) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL17355377 | 0.92 | MAOB (0.61) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL5315888 | 0.92 | MAOB (0.61) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL9523424 | 0.92 | MAOB (0.61) | CYP1B1KMT2AMEN1MAOBBCHE | |
| SCHEMBL9523652 | 0.90 | CYP1B1 (0.56) | CYP1B1KMT2AMEN1MAOBBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-59216138-A | — | — | None | — | — | JP | disclosed |
| US-20040092595-A1 | Analgesic agent | SEIWA PHARMACEUTICALS, LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| US-20030100516-A1 | Analgesic agent | SEIWA PHARMACEUTICALS, LTD. (JP) | 2003-05-29 | — | — | US | disclosed |
| EP-1118324-A1 | Analgesic agent comprising a cyclobutanedicarboxylic acid derivative | Seiwa Pharmaceutical, Limited (JP) | 2001-07-25 | — | — | EP | disclosed |
| US-6229020-B1 | REACTING N-SUCCINIMIDYL AND P-NITROPHENYL CINNAMATE DERIVATIVES WITH PHYSIOLOGICALLY ACTIVE SUBSTANCE SUCH AS AN AMINO ACID; PROTECTING AMINO OR HYDROXY GROUPS FOR ANALYSIS OF BIOLOGICAL REACTIONS BY IRRADIATION WITH LIGHT | LABORATORY OF MOLECULAR BIOPHOTONICS (JP) | 2001-05-08 | — | — | US | disclosed |
| JP-S59216138-A | SELF-SENSITIZING PHOTOSENSITIVE RESIN | RES DEV CORP OF JAPAN | 1984-12-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092595-A1 | Analgesic agent | OPRD1, FPR1, OPRK1 | CYP1B1 120/4885KMT2A 3322/4885MEN1 4851/4885 |
| US-20030100516-A1 | Analgesic agent | OPRD1, FPR1, OPRK1 | CYP1B1 120/4885KMT2A 3322/4885MEN1 4851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.